SCHEMBL4958764

SCHEMBL4958764

CCCCc1nc2ccccc2c(=O)n1-c1ccc(N2CCN(C)CC2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.71
MAPK1 P28482 1/20 0.71
ALDH1A1 P00352 2/20 0.58
CYP1A2 P05177 2/20 0.57
CYP3A4 P08684 2/20 0.57
CYP2C9 P11712 2/20 0.57
CYP2C19 P33261 2/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
KCNH2 Q12809 2/20 0.57
HRH3 Q9Y5N1 2/20 0.57
CYP2D6 P10635 1/20 0.57
SMN1; SMN2 Q16637 2/20 0.53
BLM P54132 1/20 0.53
PDE10A Q9Y233 1/20 0.53
HTR7 P34969 5/20 0.52
PDE4A P27815 1/20 0.52
PDE4B Q07343 1/20 0.52
PDE4C Q08493 1/20 0.52
PDE4D Q08499 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4959496 0.90 LMNA (0.73) LMNAMAPK1ALDH1A1CYP1A2CYP3A4
SCHEMBL4957364 0.89 LMNA (0.71) LMNAMAPK1ALDH1A1CYP1A2CYP3A4
SCHEMBL4957819 0.88 LMNA (0.71) LMNAMAPK1ALDH1A1CYP1A2CYP3A4
SCHEMBL14115519 0.88 LMNA (0.70) LMNAMAPK1ALDH1A1CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL4955827 0.87 LMNA (0.69) LMNAMAPK1ALDH1A1CYP1A2CYP3A4
SCHEMBL4957089 0.83 LMNA (1.00) LMNAMAPK1ALDH1A1CYP1A2CYP3A4
SCHEMBL4958242 0.82 LMNA (0.80) LMNAMAPK1ALDH1A1CYP1A2CYP3A4
SCHEMBL4958923 0.82 LMNA (0.80) LMNAMAPK1ALDH1A1CYP1A2CYP3A4
SCHEMBL4958462 0.82 LMNA (0.80) LMNAMAPK1ALDH1A1CYP1A2CYP3A4
SCHEMBL4958937 0.82 LMNA (0.80) LMNAMAPK1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed